124 related articles for article (PubMed ID: 4061371)
21. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
McGuire WP; Blessing JA; Yordan E; Beecham J
Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
[TBL] [Abstract][Full Text] [Related]
22. Epirubicin and cisplatin in recurrent, metastatic or advanced carcinoma of the cervix.
Lorvidhaya V
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():252-5. PubMed ID: 7661592
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Adcock L; Webster KD; DeEulis T
Invest New Drugs; 1989 Nov; 7(4):341-3. PubMed ID: 2513286
[TBL] [Abstract][Full Text] [Related]
25. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
26. Effective chemotherapy for advanced carcinoma of the cervix with bleomycin, cisplatin, vincristine, and methotrexate.
Rosenthal CJ; Khulpateea N; Boyce J; Mehrotra S; Tamarin S
Cancer; 1983 Dec; 52(11):2025-30. PubMed ID: 6194875
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin-cisplatin combination chemotherapy for recurrent carcinoma of the cervix.
Tropé C; Horvath G; Haadem K; Gudmundsson T; Simonsen E
Cancer Treat Rep; 1986 Nov; 70(11):1325-6. PubMed ID: 3768874
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.
Wagenaar HC; Pecorelli S; Mangioni C; van der Burg ME; Rotmensz N; Anastasopoulou A; Zola P; Veenhof CH; Lacave AJ; Neijt JP; van Oosterom AT; Einhorn N; Vermorken JB
Eur J Cancer; 2001 Sep; 37(13):1624-8. PubMed ID: 11527687
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Muggia FM; Blessing JA; McGehee R; Monk BJ
Gynecol Oncol; 2004 Aug; 94(2):483-7. PubMed ID: 15297192
[TBL] [Abstract][Full Text] [Related]
30. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide.
Morris M; Gershenson DM; Eifel P; Silva EG; Mitchell MF; Burke TW; Wharton JT
Gynecol Oncol; 1992 Oct; 47(1):62-5. PubMed ID: 1330847
[TBL] [Abstract][Full Text] [Related]
31. A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix.
Papadimitriou CA; Dimopoulos MA; Giannakoulis N; Sarris K; Vassilakopoulos G; Akrivos T; Voulgaris Z; Vlahos G; Diakomanolis E; Michalas S
Cancer; 1997 Jun; 79(12):2391-5. PubMed ID: 9191528
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of cisplatin and razoxane (ICRF-159) (NSC #119875) in advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Pilot Study.
Bonomi P; Yordan E; Blessing JA
Am J Clin Oncol; 1988 Feb; 11(1):1-2. PubMed ID: 3277372
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
[TBL] [Abstract][Full Text] [Related]
34. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
35. [The immediate results of the combined chemotherapy of disseminated forms and recurrences of cervix uteri cancer with vincristine, platidiam and adriamycin].
Zabunov AV; Dudareva LA
Vopr Onkol; 1991; 37(11-12):1090-4. PubMed ID: 1669203
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
37. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
[TBL] [Abstract][Full Text] [Related]
38. Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine).
Soeters R; Bloch B; Levin W; Dehaeck CM; Goldberg G
Gynecol Oncol; 1989 Apr; 33(1):44-5. PubMed ID: 2467844
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix.
Kavanagh JJ; Gershenson D; Copeland L; Roberts WS
J Clin Oncol; 1987 Oct; 5(10):1621-3. PubMed ID: 3655859
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
